Amgen, Inc. (AMGN)

331.49 +0.10 (+0.03%) USD  |  NASDAQ  |  Dec 23, 16:00
331.35 -0.14 (-0.04%) After-Hours: 20:00
More

Amgen SG&A Expense (TTM): 6.976B for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for AMGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Biogen, Inc. 2.431B
Gilead Sciences, Inc. 5.886B
Johnson & Johnson 23.38B
Eli Lilly & Co. 10.39B
Regeneron Pharmaceuticals, Inc. 2.717B